OHSU

Leukemia Treatment

Leukemia Cancer Treatment

At OHSU Knight Cancer Institute, we personalize leukemia treatment. Our leukemia team is led by internationally renowned oncologist Dr. Brian Druker. We offer the latest treatment options and pioneering leukemia research.

Leukemia Treatment At OHSU Knight Cancer Institute

Leukemia Treatment at OHSU Knight Cancer Institute

We see patients with acute and chronic leukemia (AML, APL, ALL, CML, CMML and CLL). 

Your first treatment for leukemia is by far the most important. At OHSU Knight Cancer Institute, you can expect to receive the best leukemia care available. You’ll also have access to advanced treatments being developed in clinical trials for leukemia.

Meet Your Leukemia Doctors

Find Out More About Leukemia

Learn More About Leukemia Treatments


Leukemia Clinical Trials

Clinical Trials

Not all patients are cured with standard leukemia treatment, and some standard treatments have more side effects than you want to live with. If this is true for you, you might seek help through a clinical trial to treat your leukemia. Patients who participate in clinical trials have the first chance to benefit from leukemia treatments that have shown promise in earlier research. They also make an important contribution to healthcare by helping leukemia doctors learn more about the disease.

Learn More About Leukemia Clinical Trials


 Beat AML

My Knight Cancer Story

Rob Shick discusses his leukemia treatment and prognosis at OHSU Knight Cancer Institute

At age 44, Rob Shick had always been healthy and active, so he was shocked to hear that he had leukemia. He started taking Gleevec, the cancer drug developed by OHSU Knight Cancer Institute Director Dr. Brian Druker. “Within five weeks, my blood count was back in the normal range,” Rob says. He never missed a day of work, a workout or any of his children’s activities.

Learn More About My Leukemia Treatment. Watch Video

Upcoming Events